News
Even with an estimated 25 percent premium increase, 78 percent of marketplace consumers should be able to find plan for $100 per month or less.
FDA approved drug Exondys 51 made by Sarepta Therapeutics to treat Duchenne muscular dystrophy.
Massive settlement with DOJ allows EpiPen maker to avoid admitting wrongdoing in how it has classified the emergency allergy treatment since 2007.
Those cared for at higher-cost hospitals have no greater chance of survival, the study found.
Obamacare an issue at ugly, bitter debate, but claims about cost spikes were exaggerated, experts say.
The new CMS model allows insurers to design specific benefits to enrollees with a combination of chronic conditions.
Group sent a letter to CMS requesting transparent processes for dealing with MIPS, a shorter reporting period and lower thresholds for MIPS exclusions.
Deal will be funded with available cash, and is due to close by first quarter 2017, company says.
There are several measures Trump could take on Day One of his presidency to cripple the law's effectiveness.
Overall, healthcare has added 445,000 jobs in the past 12 months.